Company Elanix Biotechnologies AG
Equities
ELN
DE000A0WMJQ4
Biotechnology & Medical Research
Business Summary
Number of employees: 11
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 11-12-31 | |
Egon Minar
DFI | Director of Finance/CFO | - | 18-05-28 |
Chief Tech/Sci/R&D Officer | - | - | |
Public Communications Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Marco Christen
CHM | Chairman | - | 20-02-26 |
Director/Board Member | - | 21-05-03 | |
Director/Board Member | - | 23-02-09 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 8,080,902 | 3,264,982 ( 40.40 %) | 0 | 40.40 % |
Company contact information
Elanix Biotechnologies AG
Hanauer Landstrasse 291 B
60314, Frankfurt
+
http://www.elanix-biotechnologies.deSector
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |